Olon USA

Speed, flexibility, and precision are critical in the early stages of drug development. At Olon USA, we specialize in targeted custom synthesis that allows pharmaceutical companies to innovate faster and more efficiently. Learn how we empower pharma partners to develop cutting-edge therapies through tailored chemistry solutions in our latest blog: https://lnkd.in/g8z3c5q4 From scaling complex chemistries to ensuring regulatory compliance, Olon USA’s small-scale chemistry capabilities empower your team to focus on what matters most—bringing life-saving therapies to patients faster. #SmallScaleChemistry #SmallScaleSolutions #DrugInnovation #PharmaDevelopment

At Olon USA, we understand the unique challenges small pharma companies face when developing new therapies. Our Kilo Lab is designed to offer flexible API production solutions that scale with your needs. In our latest blog, we highlight how this facility enables small batches of high-quality APIs, helping you navigate from early development to clinical trials with confidence. Read more about how our Kilo Lab can support your API needs: https://lnkd.in/gmwnyPtD Whether you're in the initial stages or looking to scale up, Olon USA provides the support and expertise to accelerate your journey. #PharmaDevelopment #APISolutions #SmallPharma #KiloLab

At Olon USA, we know that even the smallest impurity can have a significant impact on pharmaceutical products. In our latest blog, we dive into the intricate process of finding those elusive impurities – the “needle in the haystack” – that could impact drug safety and efficacy. By leveraging advanced analytical tools and industry expertise, we help you navigate the complexities of impurity detection—ultimately enhancing the quality and compliance of your products. Read more about our approach and solutions here: https://lnkd.in/g54mFGaG Whether you're tackling trace impurities or aiming for complete characterization, Olon USA is your partner in precision and reliability. #PharmaceuticalDevelopment #ImpurityIsolation #ImpurityCharacterization #DrugSafety #PharmaceuticalSolutions 

#Olon announcement of new #acquisition by Contract Pharma https://lnkd.in/dautwis2

When it comes to drug development, precision is more than a goal—it’s a necessity. At Olon USA, we pride ourselves on delivering custom stable labeled bioanalytical standards that provide the accuracy you need to move your projects forward with confidence. Our latest blog delves into how our tailor-made solutions are crafted to meet the specific needs of your projects. Learn how we bring together advanced technology, in-depth scientific knowledge, and a commitment to quality to support your journey from discovery to market. Click here to read more: https://lnkd.in/gw_jD9hB #BioanalyticalStandards #DrugDevelopment #Pharma #StableLabeling #InnovativeSolutions

Join Olon USA as we make our mark at CPHI Worldwide 2024 in Milan, Italy! Visit us at Stand 1B2, API to explore our state-of-the-art API development and manufacturing services. Discover our comprehensive risk management strategies, client-centric services, and tailored solutions for all phases of drug development. Click here to learn more: https://lnkd.in/gcQyTe7b Don't miss the chance to book a meeting with our experts and explore how we can drive your projects forward with efficiency and innovation. #CPHIWorldwide2024 #DrugDevelopment #APIManufacturing #Olon #OlonUSA

We are pleased to announce that we have obtained the CEP for the active ingredient #Rotigotine, ready to supply the product as flexible and sustainable source, EU registered and CEP based countries. Rotigotine is a molecule used to treat #Parkinson's Disease. #Olon has developed a proprietary, innovative process that allows us to obtain a product with a particularly high degree of purity and high efficiency standards. “The international collaboration between Italy and the United States was key to achieving the brilliant result. The work teams have successfully finalized the technology transfer of the product to Olon USA so that we are able to provide the API from different sites and satisfy the different regulatory and patent needs of customers" @Giorgio Bertolini, Senior VP R&D, commented

We're thrilled to announce a game-changing development at Olon USA! Our parent company, Olon, has acquired GTP Bioways, a leading French CDMO specializing in biopharmaceutical development. This strategic move expands our capabilities, allowing us to offer a comprehensive range of services from small molecule to large molecule development and manufacturing. Click here to learn more: https://lnkd.in/ga48K4qD We're excited to support our clients with even more innovative solutions, particularly in the rapidly growing oncology space. #OlonUSA #Olon #BioPharma #Oncology #DrugDevelopment

ONCOLOGY. FROM CYTOTOXIC COMPOUNDS TO HIGHLY SELECTIVE APPROACHES. Read the full story of our long lasting expertise in manufacturing #API in high containment. This is the thought leadership article by Giorgio Bertolini published by Specialty Chemicals Magazines Thank you Andrew Warmington https://joom.ag/Njtd/p24